PRESS DIGEST-British Business - June 10
Paramount Skydance PSKY | 0.00 | |
Warner Bros Discovery WBD | 0.00 | |
Nuvalent, Inc. Class A NUVL | 0.00 | |
GlaxoSmithKline plc Sponsored ADR GSK | 0.00 | |
Palantir PLTR | 0.00 |
June 10 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
The Times
- GlaxoSmithKline GSK.L has struck a deal to buy Nuvalent NUVL.O, a U.S. oncology-focused biopharmaceutical company, for $10.6 billion.
- The UK Metropolitan Police has defended the use of Palantir PLTR.O to identify misconduct and corruption after Sir Sadiq Khan, the London mayor, vetoed a £50 million deal with the American tech firm.
The Guardian
- The UK competition watchdog has opened an investigation into Paramount Skydance's PSKY.O $110 billion takeover of Warner Bros Discovery WBD.O.
The Telegraph
- UK's Boots is in talks to sell itself for £7.5 billion to the family behind Primark and an Australian pharmacy chain.
Sky News
- UK's Ministry of Defence and UK Space Agency are extending the backing for a flagship ‘deeptech’ fund as part of a £33 million funding package that will be deployed across several cornerstones of Britain’s industrial strategy.